The global Schizophrenia Therapeutics Market is witnessing renewed interest driven by rising awareness, improved diagnostics, and expanding treatment modalities. Analysts expect robust expansion as unmet needs and technological advances align. This market brief provides insights into key drivers, challenges, financial bearings, and future opportunities shaping the sector. Growing research...